Category: BioTrace MedicalSyndicate content

Stealthy BioTrace Medical reels in $3.4M

March 4, 2014 by Chris Walker

Stealthy BioTrace Medical brings in $3.4 million in a hoped-for $3.5 million round for the heart pacing technology it's developing.

BioTrace Medical brings in $3.4M

BioTrace Medical is closing in on its $3.5 million goal, having raised $3.4 million in a funding round, according to a regulatory filing.

BioTrace, which is backed by early-stage medtech angel Xandex Investments, is developing a temporary cardiac pacing device to treat reversible symptomatic bradycardia.